Clinical trial reportNature medicinePublished
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Regional connection
Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source
- Institution
- The Wistar Institute
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Nature medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Vaccines; Antibodies, Monoclonal, Humanized
- PubMed ID
- 38584166
- PubMed Central ID
- PMC11031401
- Open access
- Yes, open
- Added to directory
- Source checked